A Study Designed to Evaluate Tear Production
NCT06544707
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
81
Enrollment
INDUSTRY
Sponsor class
Conditions
Dry Eye Disease
Interventions
DRUG:
0.003% AR-15512 ophthalmic solution
Sponsor
Alcon Research